File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S1368-8375(99)00029-9
- Scopus: eid_2-s2.0-0032705132
- PMID: 10705088
- WOS: WOS:000083287100003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis
Title | Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis |
---|---|
Authors | |
Keywords | Fas FasL Oral Premalignant lesions Squamous cell carcinoma |
Issue Date | 1999 |
Publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/oraloncology |
Citation | Oral Oncology, 1999, v. 35 n. 6, p. 548-553 How to Cite? |
Abstract | An important molecule involved in delivering the death signal that initiates apoptosis is called Fas, or Apo-1, which sits on the cell surface. When another molecule called the Fas ligand (FasL) binds to it, Fas triggers a series of events inside the cell that leads to apoptosis. In order to investigate the mechanism of immune escape and the expression of Fas and FasL in oral premalignant lesions (OPLs) and oral squamous cell carcinomas (OSCCs), a total of 64 samples were evaluated by an immunohistochemical method using a labelled streptavidin-biotin assay. These samples comprised nine hyperkeratotic and 24 oral premalignant lesions (nine of mild, moderate, and six of severe dysplastic lesions), and 24 OSCCs, together with seven healthy controls. The results demonstrated that the majority of invasive OSCCs showed down-regulation of Fas expression but up-regulation of FasL expression. These phenomena were also detected in OPLs. The results indicate that the expression of Fas and FasL is involved in oral carcinogenesis and this may be a mechanism by which the cancer cells evade the host immune assault. Perhaps, in future, Fas/FasL system may be used as a prognostic biomarker in predicting the behavior of oral premalignant lesions. |
Persistent Identifier | http://hdl.handle.net/10722/66443 |
ISSN | 2023 Impact Factor: 4.0 2023 SCImago Journal Rankings: 1.257 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chen, Q | en_HK |
dc.contributor.author | Samaranayake, LP | en_HK |
dc.contributor.author | Zhen, X | en_HK |
dc.contributor.author | Luo, G | en_HK |
dc.contributor.author | Nie, M | en_HK |
dc.contributor.author | Li, B | en_HK |
dc.date.accessioned | 2010-09-06T05:46:24Z | - |
dc.date.available | 2010-09-06T05:46:24Z | - |
dc.date.issued | 1999 | en_HK |
dc.identifier.citation | Oral Oncology, 1999, v. 35 n. 6, p. 548-553 | en_HK |
dc.identifier.issn | 1368-8375 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/66443 | - |
dc.description.abstract | An important molecule involved in delivering the death signal that initiates apoptosis is called Fas, or Apo-1, which sits on the cell surface. When another molecule called the Fas ligand (FasL) binds to it, Fas triggers a series of events inside the cell that leads to apoptosis. In order to investigate the mechanism of immune escape and the expression of Fas and FasL in oral premalignant lesions (OPLs) and oral squamous cell carcinomas (OSCCs), a total of 64 samples were evaluated by an immunohistochemical method using a labelled streptavidin-biotin assay. These samples comprised nine hyperkeratotic and 24 oral premalignant lesions (nine of mild, moderate, and six of severe dysplastic lesions), and 24 OSCCs, together with seven healthy controls. The results demonstrated that the majority of invasive OSCCs showed down-regulation of Fas expression but up-regulation of FasL expression. These phenomena were also detected in OPLs. The results indicate that the expression of Fas and FasL is involved in oral carcinogenesis and this may be a mechanism by which the cancer cells evade the host immune assault. Perhaps, in future, Fas/FasL system may be used as a prognostic biomarker in predicting the behavior of oral premalignant lesions. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/oraloncology | en_HK |
dc.relation.ispartof | Oral Oncology | en_HK |
dc.subject | Fas | - |
dc.subject | FasL | - |
dc.subject | Oral | - |
dc.subject | Premalignant lesions | - |
dc.subject | Squamous cell carcinoma | - |
dc.subject.mesh | Antigens, CD95 - metabolism | en_HK |
dc.subject.mesh | Apoptosis | en_HK |
dc.subject.mesh | Carcinoma, Squamous Cell - metabolism | en_HK |
dc.subject.mesh | China | en_HK |
dc.subject.mesh | Down-Regulation | en_HK |
dc.subject.mesh | Fas Ligand Protein | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Immunohistochemistry | en_HK |
dc.subject.mesh | Membrane Glycoproteins - metabolism | en_HK |
dc.subject.mesh | Mouth Neoplasms - metabolism | en_HK |
dc.subject.mesh | Up-Regulation | en_HK |
dc.title | Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1368-8375&volume=35&spage=548&epage=553&date=1999&atitle=Up-regulation+of+Fas+ligand+and+down-regulation+of+Fas+expression+in+oral+carcinogenesis | en_HK |
dc.identifier.email | Samaranayake, LP:lakshman@hku.hk | en_HK |
dc.identifier.authority | Samaranayake, LP=rp00023 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/S1368-8375(99)00029-9 | en_HK |
dc.identifier.pmid | 10705088 | - |
dc.identifier.scopus | eid_2-s2.0-0032705132 | en_HK |
dc.identifier.hkuros | 47500 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0032705132&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 35 | en_HK |
dc.identifier.issue | 6 | en_HK |
dc.identifier.spage | 548 | en_HK |
dc.identifier.epage | 553 | en_HK |
dc.identifier.isi | WOS:000083287100003 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Chen, Q=16244214800 | en_HK |
dc.identifier.scopusauthorid | Samaranayake, LP=7102761002 | en_HK |
dc.identifier.scopusauthorid | Zhen, X=7004818243 | en_HK |
dc.identifier.scopusauthorid | Luo, G=55112399500 | en_HK |
dc.identifier.scopusauthorid | Nie, M=11540273000 | en_HK |
dc.identifier.scopusauthorid | Li, B=16202895000 | en_HK |
dc.identifier.issnl | 1368-8375 | - |